Normal view MARC view ISBD view

Shen, Yuqing

GSI-I has a better effect in inhibiting hepatocellular carcinoma cell growth than GSI-IX, GSI-X, or GSI-XXI. [electronic resource] - Anti-cancer drugs Aug 2012 - 683-90 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

ISSN: 1473-5741

Standard No.: 10.1097/CAD.0b013e3283549a22 doi

Subjects--Topical Terms:
Amyloid Precursor Protein Secretases--antagonists & inhibitors
Antineoplastic Agents--therapeutic use
Basic Helix-Loop-Helix Transcription Factors--drug effects
Benzodiazepinones--therapeutic use
Calcium-Binding Proteins--drug effects
Carbamates--therapeutic use
Carcinoma, Hepatocellular--drug therapy
Cell Line, Tumor
Cell Proliferation--drug effects
Cell Survival
Dipeptides--therapeutic use
Gene Expression Regulation, Neoplastic--drug effects
Genes, myc--drug effects
Hep G2 Cells
Homeodomain Proteins--drug effects
Humans
Intercellular Signaling Peptides and Proteins--genetics
Jagged-1 Protein
Liver Neoplasms--drug therapy
Membrane Proteins--drug effects
Oligopeptides--therapeutic use
Receptors, Notch--antagonists & inhibitors
Serrate-Jagged Proteins
Transcription Factor HES-1